Center for Environmentally
Beneficial Catalysis

  • Home
  • New industry partner: Solvay

New industry partner: Solvay

Monday, March 2, 2015

CEBC welcomes Solvay as the newest industry partner . To date, the center has been privileged to work with 23 industry partners in total, including our 8 currently active partners.

Solvay is a model of sustainable chemistry, dedicating nearly 150 years to developing and delivering innovative solutions to markets and customers around the world. Solvay has one of the broadest and deepest portfolios of chemical products aimed at such critical applications as pollution control, water treatment, pharmaceutical and consumer packaging, among many others. The company’s three main chemistries are based in fluorine, peroxygen and sodium. Solvay is committed to sustainable practices, and introduced the world’s first process to reclaim sodium carbonate waste and turn it into sodium bicarbonate solutions that treat emissions of coal-fired power plants.



CEBC Calendar

September 13, Wednesday - Mandatory Lab Safety Meeting
All researchers at 1501 Wakarusa Dr. must attend

9:00 a.m. in Building B seminar room

September 19, Tuesday - CEBC Colloquium
Dr. David Sholl, Chair of Georgia Tech School of Chemical & Biomolecular Engineering
"New Nanoporous Materials for Practical Applications Using Computation Modeling - How Close Is the Dream to Reality?"

9:00 a.m. - 10:00 a.m., 1501 Wakarusa Drive, Building B seminar room
10:00 a.m. discussion with students

October 16 & 17, Monday & Tuesday - CEBC Fall Industry Advisory Board Meeting
Registration is Open - click here!

Monday 12:00-7:30 p.m. at the Adams Alumni Center, 1266 Oread Avenue, Lawrence
Tuesday 8:30-noon at the CEBC Complex, 1501 Wakarusa Drive, Lawrence

November 7, Tuesday - CEBC Industry Colloquium
Dr. Brandon Emme, Cellulose Team Leader, ICM, Inc.
"Title TBA"

9:00 a.m. - 10:00 a.m., 1501 Wakarusa Drive, Building B seminar room
10:00 a.m. discussion with students

KU Today
48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding